394 related articles for article (PubMed ID: 20622003)
21. Impact of S100A8/A9 expression on prostate cancer progression in vitro and in vivo.
Grebhardt S; Müller-Decker K; Bestvater F; Hershfinkel M; Mayer D
J Cell Physiol; 2014 May; 229(5):661-71. PubMed ID: 24122301
[TBL] [Abstract][Full Text] [Related]
22. S100A8, S100A9, and the S100A8/A9 complex in circulating blood are not associated with prostate cancer risk-A re-evaluation study.
Ludwig S; Stephan C; Lein M; Loening SA; Jung K
Prostate; 2007 Sep; 67(12):1301-7. PubMed ID: 17626245
[TBL] [Abstract][Full Text] [Related]
23. S100A8 and S100A9 are messengers in the crosstalk between epidermis and dermis modulating a psoriatic milieu in human skin.
Lee Y; Jang S; Min JK; Lee K; Sohn KC; Lim JS; Im M; Lee HE; Seo YJ; Kim CD; Lee JH
Biochem Biophys Res Commun; 2012 Jul; 423(4):647-53. PubMed ID: 22683330
[TBL] [Abstract][Full Text] [Related]
24. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.
Hermani A; De Servi B; Medunjanin S; Tessier PA; Mayer D
Exp Cell Res; 2006 Jan; 312(2):184-97. PubMed ID: 16297907
[TBL] [Abstract][Full Text] [Related]
25. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
26. Proinflammatory Proteins S100A8/S100A9 Activate NK Cells via Interaction with RAGE.
Narumi K; Miyakawa R; Ueda R; Hashimoto H; Yamamoto Y; Yoshida T; Aoki K
J Immunol; 2015 Jun; 194(11):5539-48. PubMed ID: 25911757
[TBL] [Abstract][Full Text] [Related]
27. S100A8 and S100A9 expression is a crucial factor for dedifferentiation in thyroid carcinoma.
Ito Y; Arai K; Nozawa R; Yoshida H; Hirokawa M; Fukushima M; Inoue H; Tomoda C; Kihara M; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Miyauchi A
Anticancer Res; 2009 Oct; 29(10):4157-61. PubMed ID: 19846966
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of Smad4 enhances proliferation and invasion of colorectal carcinoma HCT116 cells and up-regulates Id2.
Shi Q; Zhong YS; Yao LQ; Li QL; Ren Z; Liu XP; Shi FM
Mol Med Rep; 2012 Jan; 5(1):89-95. PubMed ID: 21956276
[TBL] [Abstract][Full Text] [Related]
29. IL-10-dependent S100A8 gene induction in monocytes/macrophages by double-stranded RNA.
Endoh Y; Chung YM; Clark IA; Geczy CL; Hsu K
J Immunol; 2009 Feb; 182(4):2258-68. PubMed ID: 19201880
[TBL] [Abstract][Full Text] [Related]
30. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
31. Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells.
Yong HY; Moon A
Arch Pharm Res; 2007 Jan; 30(1):75-81. PubMed ID: 17328245
[TBL] [Abstract][Full Text] [Related]
32. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
33. SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells.
Moz S; Basso D; Bozzato D; Galozzi P; Navaglia F; Negm OH; Arrigoni G; Zambon CF; Padoan A; Tighe P; Todd I; Franchin C; Pedrazzoli S; Punzi L; Plebani M
Oncotarget; 2016 Oct; 7(43):69927-69944. PubMed ID: 27655713
[TBL] [Abstract][Full Text] [Related]
34. Expression of surfactant protein-C, S100A8, S100A9, and B cell markers in renal allografts: investigation of the prognostic value.
Eikmans M; Roos-van Groningen MC; Sijpkens YW; Ehrchen J; Roth J; Baelde HJ; Bajema IM; de Fijter JW; de Heer E; Bruijn JA
J Am Soc Nephrol; 2005 Dec; 16(12):3771-86. PubMed ID: 16251238
[TBL] [Abstract][Full Text] [Related]
35. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis.
van Lent PL; Blom AB; Schelbergen RF; Slöetjes A; Lafeber FP; Lems WF; Cats H; Vogl T; Roth J; van den Berg WB
Arthritis Rheum; 2012 May; 64(5):1466-76. PubMed ID: 22143922
[TBL] [Abstract][Full Text] [Related]
36. [Possibility of formation of the S100A8/A9-proinflammatory cytokine complexes in vivo in acute inflammation and their functional roles].
Ishihara K; Namura T; Murayama H; Arai S; Totani M; Ikemoto M
Rinsho Byori; 2009 Apr; 57(4):324-31. PubMed ID: 19489433
[TBL] [Abstract][Full Text] [Related]
37. SMAD4 as a prognostic marker in colorectal cancer.
Alazzouzi H; Alhopuro P; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Hemminki A; Schwartz S; Aaltonen LA; Arango D
Clin Cancer Res; 2005 Apr; 11(7):2606-11. PubMed ID: 15814640
[TBL] [Abstract][Full Text] [Related]
38. The hetero-oligomeric complex of the S100A8/S100A9 protein is extremely protease resistant.
Nacken W; Kerkhoff C
FEBS Lett; 2007 Oct; 581(26):5127-30. PubMed ID: 17936757
[TBL] [Abstract][Full Text] [Related]
39. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
40. S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast.
Arai K; Takano S; Teratani T; Ito Y; Yamada T; Nozawa R
Curr Cancer Drug Targets; 2008 Jun; 8(4):243-52. PubMed ID: 18537548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]